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 Stroke is the fourth leading cause of death in the United States and is a leading 
cause of long-term disability. More than 795,000 people have a stroke annually. Ischemic 
strokes account for 87% of all strokes, and hemorrhagic strokes account for 13% of all 
strokes. Although family history is an indicator for both types of stroke, ischemic strokes 
are more closely related to environmental risk factors, such as diet, exercise and smoking. 
Hemorrhagic strokes also aggregate within families but often occur at younger ages 
indicating a possible genetic link. The purpose of this study was to identify similarities 
and differences of the biological risk factors associated with hemorrhagic stroke, such as 
hypertension, diabetes mellitus and/or high cholesterol, and environmental risk factors, 
such as exercise, alcohol consumption, smoking, and perceived stress within and between 
families with a history of hemorrhagic stroke.  
 Methods: 14 individuals (8 with hemorrhagic stroke, 6 without hemorrhagic 
stroke) participated from 4 families with a family history of hemorrhagic stroke were 
recruited from stroke support groups in the southeast, social media and Casa Colina 
Hospital and Medical Center in Pomona, California. Participants completed medical and 
family history questionnaires, as well as, the Health Promoting Lifestyle Profile (HPLPII) 
and the Perceived Stress Scale (PSS). 
 Results: Nonparametric statistical analysis and visual representation were utilized 
to compare biological risk factors associated with hemorrhagic stroke within and between 
families and to measure the strength and direction of association that exists between 
 
 
groups.  Hypertension was the most salient biological risk factor among all study 
participants (87%), followed by high cholesterol (42.9%) and diabetes mellitus (14.3%).  
General stress and alcohol consumption was reported in all families (50% and 57% of 
participants, respectively). Mann-Whitney U Test indicated that PSS scores were 
significantly higher for participants with hemorrhagic stroke ( =24.33) than for 
participants without hemorrhagic stroke ( =15.67), U=4.0, p=.028).  
 Conclusion: There is not one clear biological or environmental factor identified as 
the cause of familial hemorrhagic stroke; however, hypertension seems aggregate within 
families with a history of hemorrhagic stroke suggesting that it may be a major risk 
factor. In addition, perceived stress was significantly higher in participants with 
hemorrhagic stroke compared to those without hemorrhagic stroke suggesting that it is 
also a risk factor for familial hemorrhagic stroke.  
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CHAPTER I 
 
INTRODUCTION 
 
 
 Precision medicine is a term used to describe treatment and prevention of disease. 
It takes into account unique biological, environmental, and behavioral factors that drive 
disease in individuals.  It recognizes variability in environment, lifestyle and genes for 
each person (U.S. Department of Health & Human Services, 2015). Identifying and 
understanding risk factor, such as family history, social history, and medical history, 
associated with an illness is the first step in prevention of a disease. It allows physicians 
and individuals to understand the pattern of disease and helps in planning a course of 
action which may reduce risk. One such disease that can benefit from precision medicine 
is stroke.  
Stroke is the fourth leading cause of death in the United States when considered 
separately from other cardiovascular diseases, such as heart disease, coronary artery 
disease, and arrhythmias. It is a leading cause of long-term disability in the United States.  
More than 795,000 people have a stroke annually, costing an estimated $34 billion each 
year.  According to the National Institutes of Health, National Heart, Lung, and Blood 
Institute (2015), 25% of people with a stroke will have another stroke within 5 years. Of 
these, 87% are ischemic, and 13% are hemorrhagic (Mozaffarian et al., 2015).  Forty 
percent of hemorrhagic strokes end in death within 30 days (Woo et al., 2002).  
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Several long-term effects of stroke exist, including aphasia, which occurs in 21%-
35% of strokes, and dysphagia, which affects more than 50% of stroke survivors 
(Martino et al., 2005).  One way to avoid the long-term effects of stroke is to prevent 
stroke.  The American Speech, Language and Hearing Association (ASHA) recognizes 
the importance of prevention of communication disorders as one of the profession’s 
primary responsibilities.  In 1973, the ASHA Legislative Council approved a policy 
statement entitled “Prevention of Communication Problems in Children.”  Since then, the 
statement has been modified to include all age groups.  ASHA (1988) acknowledges that  
the traditional role of the speech-language pathologist in the identification and treatment 
of communication disorders has expanded to now include efforts to “eliminate the onset 
of communication disorders.” One way to accomplish this is to determine the 
epidemiologies of specific communication disorders (ASHA, 1988), such as aphasia and 
dysphagia. Once the specific causes have been identified, preventative practices can be 
initiated with at risk populations, such as individuals with a family history of stroke.     
Because ischemic stroke occurs more often than hemorrhagic stroke, the risk 
factors associated with it are more widely understood.  For example, high blood pressure, 
high cholesterol, diabetes mellitus, heart disease, smoking, high body mass index (BMI) 
(Dey, Rothenberg, Sundh, Bosaeus, & Steen, 2002), race, and increasing age 
(Morgenstern, et al., 2004) are all known risk factors for ischemic stroke. Although 
several risk factors are associated with hemorrhagic stroke, they are not as clearly defined 
or necessarily well known.  For instance, there is strong evidence to support high blood 
pressure (BP) (Howard et al., 2013; Matsukawa et al., 2012; Sturgeon et al., 2007) and 
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smoking (Kissela et al., 2002; Woo et al., 2009) as risk factors for hemorrhagic stroke but 
other risk factors such as BMI (Kissela et al., 2002; Matsukawa et al., 2012; Sturgeon et 
al., 2007), high cholesterol (Sturgeon, et al., 2007; Wieberdink et al., 2011), and diabetes 
mellitus (Howard et al., 2013; Kissela et al., 2002; Woo et al., 2002) yield more 
inconclusive evidence. Family history is a strongly associated risk factor for both 
ischemic stroke (Choi, Lee, Kang, Kang, & Bae, 2009; Jerrad-Dunne, Cloud, Hassan, & 
Markus, 2003) and hemorrhagic stroke (Kissela et al., 2002; Woo et al., 2002; Woo et al., 
2009). Ischemic and hemorrhagic strokes can occur at any age; however, hemorrhagic 
strokes that aggregate within families occur at a younger age suggesting a genetic link 
(Bromber et al., 1996, Schievink, Schaid, Rogers, Piepgras, & Michels, 1994).   
Two subtypes of hemorrhagic stroke exist: intracerebral hemorrhage (ICH) and 
subarachnoid hemorrhage (SAH).  ICH results when the bleeding occurs inside the brain 
and accounts for 10% of all hemorrhagic strokes.  SAH occurs when the bleeding is in 
the subarachnoid space between the cerebrum and the arachnoid mater and accounts for 
3% of all hemorrhagic strokes (Mozaffarian et al., 2015).  
The causes of hemorrhagic strokes are multifactorial but appear to have a strong 
familial link (Kissela, et al., 2002; Woo et al., 2002; Woo et al., 2009).  The low 
incidence and high mortality rates make it difficult to determine a specific genetic source. 
Each gene has its own individual purpose and plays an important role in maintaining 
balance within the vascular system. Two genes that have been specifically related to cell 
integrity and thus resulting in hemorrhagic strokes are cerebral cavernous malformation 
(CCM) pathway genes (Gore, Lampugnani, Dye, Dejana, & Weinstein, 2008) and 
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COL4A1/COL4A2 genes (Gould et al., 2006; Jeanne, Jorgensen, & Gould, 2015). 
Mutations in either of these gene groups significantly increase the risk of hemorrhages. 
CCM genes code for the malcavernin protein, which is involved in angiogenesis, defined 
as the process in which new blood vessels form.  The malcavernin protein strengthens the 
interactions between cells that form blood vessels and limits leakage from the vessel 
(National Library of Medicine [NLM], 2016).  For COL4A1/COL4A2, increased blood 
flow, which occurs while exercising or during the stress of the natural birth process, 
increases the risk even more, demonstrating that the interaction between genes and 
environment is an important component of disease outcome (Gould et al., 2006; Jeanne et 
al., 2015).  
 Hypertension is a primary risk factor for hemorrhagic stroke.  It is the result of 
high blood pressure and is described in four stages based on systolic and diastolic 
pressure. Systolic BP 120-139 mmHg or diastolic BP 80-89 mmHg is considered 
prehypertension. Systolic BP 140 to 159 mm Hg or diastolic BP 90 to 99 mm Hg is Stage 
I. Stage II is a systolic BP 160 mm Hg to 179 mm Hg or diastolic BP 100 to 109 mm Hg. 
Stage III hypertension is a systolic BP ≥160 mm Hg or diastolic BP ≥110 mm Hg. Higher 
stages of hypertension significantly increase the risk of ICH (Chobanian et al., 2003; 
Howard et al., 2013; James et al., 2014).  As blood pressure builds, it can cause already 
weakened blood vessels in the brain to rupture, resulting in a hemorrhagic stroke.   
Blood pressure is affected by fluctuations in hormones. The ACE gene is part of 
the renin-angiotensin-aldosterone system (RAAS).  RAAS is a hormone system that 
regulates blood pressure and bodily fluids.  It functions as an endocrine axis in which the 
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active hormone, angiotensinogen, and angiotensin II is formed (Atlas, 2007).  Long-term 
angiotensinogen concentration, such as during pregnancy, may be a risk factor for 
hypertension (Atlas, 2007).  Activation of angiotensin II increases blood pressure (Atlas, 
2007).  The most common genetic variation related to RAAS is the insertion/deletion 
polymorphism of the ACE gene (ACE I/D). ACE D carriers make more ACE protein 
which results in a more active RAAS system than that of variant I carriers. A more active 
RAAS system results, such as ACE DD variant, increased sensitivity to sodium intake 
and produces a higher risk of hypertension as well as stroke and CHD (Dengel, Brown, 
Ferrell, & Supiano, 2001).  It is also significantly associated with ICH, and can result in 
smooth muscle cell death and collagen deposition (Fleming, 2006).  
The association between cholesterol levels and hemorrhagic stroke is not as clear 
as the relationship between hypertension and hemorrhagic stroke. ApoE (apolipoprotein 
E) protein is one of the key lipoproteins of lipoprotein complexes that regulate the 
metabolism of lipids by directing their transport, delivery, and distribution from one 
tissue or cell type to another through apoE receptors and proteins associated with lipid 
transfer and lipolysis (Mahley, 1988).  Higher levels of cholesterol are associated with 
higher levels of apoE protein.  The APOE ԑ4 variant is associated with faster cholesterol 
metabolism resulting in higher cholesterol levels, whereas the APOE ɛ2 variant is 
associated with slower cholesterol metabolism resulting in lower cholesterol level.  Both 
APOE ɛ4 and ɛ2 have been associated with lobar ICH and play a role in the pathogenesis 
of amyloid angiopathy (Charidimou et al., 2015).  
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Some studies suggest that the type and location of hemorrhagic stroke is 
specifically related to a genotype or specific environmental factors.  Type refers to ICH 
and SAH; whereas, location refers to the specific area of the brain where the hemorrhage 
occurred and can be divided into lobar and nonlobar (e.g. basal ganglia, thalamus, 
brainstem, cerebellum or periventrical white matter).  Martini and colleagues (2012) 
found that first time patients with lobar ICH were more likely to have the APOE ɛ2 or ɛ4 
genotype whereas the nonlobar ICH group were more likely to have high cholesterol 
and/or hypertension.  Nieuwkamp and colleagues (2014) studied SAH within two groups: 
those with artherogenic risk factors (e.g. hypertension and smoking) and those without 
artherogenic risk factors and found that the middle cerebral artery was the site of 
aneurysm for most SAH regardless of group.  These were both population-based studies 
and did not consider family history as a necessary risk factor.  Other undetermined risk 
factors may not have been reported.   
Individuals are more likely to make health changes based on family history when 
informed about the risks (Ruffin et al., 2001).  In recent years, there has been a greater 
push to use family histories in medical settings to help inform patients of their risk for 
certain diseases.  Healthcare professionals agree that patients’ ability to recognize and 
understand their risk factors based on family history is important to the patients’ overall 
health, and directly targeting and educating patients known to have a family history of a 
disease is desirable.  However, one study found that most healthcare professionals who 
participated in the study did not consider it feasible (Heideman, Cleijne, Van, Snoek, & 
Cornel, 2013).  Indeed, several barriers are recognized by healthcare professionals, such 
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as time-effectiveness and cost of administering and reviewing family histories (Heideman 
et al., 2013), as well as the concern that patients will not follow suggestions given.   
Although hemorrhagic stroke has a low incidence rate, it has a high mortality rate. 
Identifying the biological and environmental risk factors for hemorrhagic stroke within 
and between families could be an important first step for decreasing the risk of 
hemorrhagic stroke within the general population.  One study found that 10.7% of 
families within a Utah population had a positive family history of stroke.  This group 
accounted for 86% of early strokes and 68% of strokes regardless of age (Hunt, Gwinn, 
& Adams, 2003).  However, it is unclear if the stroke risk was attributed to genes, 
environment, or a combination of both.   
It is unlikely that there is one gene that guarantees an individual will acquire a 
hemorrhagic stroke; instead, it is more likely that there are several genes that interact 
with each other and the environment that would result in hemorrhagic stroke. The first 
step in understanding and identifying genetic and environmental risk factors for 
hemorrhagic stroke is choosing families with a strong family history of hemorrhagic 
stroke to study.  Next, administering a cost-effective questionnaire to these families to 
determine commonalities between and within groups may help to develop a clear picture 
of familial hemorrhagic stroke.  Gathering an in-depth family history may help 
researchers identify the potential causes in order to prevent this life threatening disease. 
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CHAPTER II 
 
LITERATURE REVIEW 
 
 
 The cause of hemorrhagic stroke is multifactorial but appear to have a strong 
familial link (Kissela et al., 2002; Woo et al., 2009; Woo et al., 2002).  Defining and 
understanding family history may be an important step in the prevention of hemorrhagic 
stroke and thus the prevention of communication disorders associated with this disease.  
Several biological and environmental factors have been identified as potential risk factors 
for hemorrhagic stroke.  The low incidence rate of hemorrhagic stroke makes the 
assessment of these risk factors difficult.  In order to understand why some individuals 
will have a hemorrhagic stroke and others will not, it is important to clearly identify the 
genetic and environmental risk factors and how these influence the cellular underpinning 
that results in hemorrhagic stroke.  
Family History  
 Family health history is one of the strongest predictors of a patient’s risk for 
complex diseases.  Family history of a disease captures the underlying complexities of 
gene—gene and gene—environment interactions by identifying families with 
combinations of risk factors that lead to disease expression (Hunt, Gwinn, & Adams, 
2003).  Collecting this information can dramatically improve identification of at-risk 
individuals (Qureshi et al., 2012; Wu et al., 2014).  Discussing the importance of family 
history and risk factors of disease with families prior to obtaining a health assessment 
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significantly improves the quantity and quality of the data provided so that appropriate 
preventive care can be given (Wu et al., 2014).  For example, a family history of 
hemorrhagic stroke increases the risk of hemorrhagic stroke (Woo et al., 2009).  This is 
especially true if a first-degree relative had a hemorrhagic stroke prior to the age of 65. 
Familial aggregation of ICH has been observed, and the heritability of ICH risk has been 
estimated at 44% (Carpenter, Singh, Gandhi, & Prestigiacomo, 2016).  
 A strong, documented relationship exists between family history of SAH and 
subsequent SAH.  One study found a sevenfold increase in SAH for first-degree relatives 
compared to second-degree relatives with SAH (Bromberg et al., 1995).  In another 
study, Korja and colleagues (2010) conducted a large twin cohort study to determine the 
heritability of SAH in a Nordic population, comparing monozygotic twins to dizygotic 
twins, and found that 41% were heritable.  In addition, researchers determined that 
although genetic factors in the etiology of SAH played a moderate role, environmental 
factors also play a significant role in SAH susceptibility at the population level (Korja et 
al., 2010).  
Biological and environmental risk factors for hemorrhagic stroke can differ 
between families. Individuals with a biological predisposition for hemorrhagic stroke can 
be compounded by environmental factors. According to Hunt and colleagues (1986),  
 
determining whether a person has a positive family history of disease can be 
important clinically, epidemiologically and genetically because unaffected 
members of positive family history families tend to have increased risk of 
developing the disease in the future (p. 809).   
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The Health Family Tree Study (Hunt et al., 1986) included 122,155 family histories from 
students at a Utah high school to determine the risk of CHD and high blood pressure 
based on a positive family history.  As part of the curriculum of a required health or 
physiology class, a specific first-degree family medical history was obtained from the 
parents of the students. Positive family history was determined using the number of 
affected first-degree relatives and whether the age of disease onset was early (< 55) or 
late (≥ 55) and using a quantitative family history score (FHS).  The FHS was based on 
the overall observed number of events in the family and the expected number calculated 
by multiplying the age and sex specific person-years of experience (number of years with 
disease) of the family by the age and sex specific incidence rates of the general 
population.  
Researchers found that using two or more affected family members as a minimum 
definition of a positive family history or using FHS ≥ 1 provided useful family history 
categorization.  Comparing FHS ≥ 2 and FHS ≥1, the relative risk of high blood pressure 
increased from 20 – 59 years of age in males.  As males aged, the relative risk leveled 
out.  For females, there was little change in the relative risk between FHS ≥ 2 and FHS 
≥1, regardless of age.  However, regardless of age or sex, having two or more first-degree 
family relatives with hypertension increased the relative risk.  Information not available 
from families was classified as “uninformative family history” rather than a negative 
family history, which decreased study bias.  Coronary heart disease (CHD) was defined 
as having a heart attack or bypass surgery.  CHD incidence rates for each family history 
group were calculated by following the family members who were unaffected for 8, 13,  
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and 18 years.  Researchers reported data only for year 8.  Risk of CHD significantly 
increased as the number of first-degree relatives with CHD increased or having an FHS ≥ 
1. 
The continuous nature of the FHS allowed for every family to be ranked and used 
in the analysis of family history.  Using the FHS or two or more affected family members 
as a minimum definition of a positive family history resulted in similar results.  This 
suggests that obtaining an in-depth family history can be a good predictor for disease.  It 
also shows that the more first-degree family members affected or the higher the FHS, the 
greater relative risk there was for both high blood pressure and CHD.  
A later study that included the Health Family Tree Study and the National Heart, 
Lung, and Blood Institute Family Heart Study (Williams et al., 2001) determined the 
cost-effectiveness of using a family health questionnaire as a tool for family-based 
preventive medicine and medical research.  This study utilized the family risk score 
(FRS) (formally FHS) as it pertains to four diseases: diabetes, hypertension, CHD, and 
stroke.  Researchers found 79% sensitivity, 91% specificity, 67% predictive value of a 
positive report, and 96% predictive value of a negative report for CHD when using the 
questionnaire.  In addition, the cost for collecting and computerizing the initial family 
history was about $10 per participating proband (mail form, follow-up call, input form, 
postage, and materials).  For validating information gathered, the cost was approximately 
$50 per proband.  Furthermore, researchers found that for stroke, 10.7% of families had a 
positive family history.  This group accounted for 86% of early strokes and 68% of 
strokes at any age.  For the 13,106 families with a high risk for strokes, a cost of $27 per 
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high-risk family was identified.  Interestingly, researchers found that positive family 
histories for all four disorders were significantly associated with each other in 2 x 2 
contingency table analysis.  The relatively low cost of compiling a family history is a 
validated tool for family-based preventative medicine and medical research.  
Many variables can influence why a disease affects one family and not another. 
For example, environmental factors, such as dietary choices, smoking, or exercise and 
genetic factors, such as family history of high blood pressure, stroke, or even a specific 
gene variant may increase the risk of hemorrhagic stroke within certain families.  Family 
history can help differentiate between environmental and genetic factors providing 
individuals a more comprehensive understanding of specific risk factors for hemorrhagic 
stroke.  Although hemorrhagic stroke affects only a small portion of the population, it is a 
devastating disease with a high mortality rate. If individuals with a family history of 
hemorrhagic stroke were aware of the underlying pathophysiology of the risk factors, 
they may begin to make changes to their lifestyle or monitor their health status to 
decrease their risk.  
Pathophysiology of Hemorrhagic Stroke 
Hemorrhagic stroke occurs when a weakened blood vessel ruptures and bleeds 
into the brain.  It causes injury to brain tissue by disrupting connecting pathways and 
causing localized pressure injury.  Two types of weakened blood vessels typically cause 
hemorrhagic stroke: aneurysm and arteriovenous malformation (AVM).  An aneurysm is 
a ballooning of a weakened region of a blood vessel.  If left untreated, the aneurysm can 
continue to weaken until it ruptures and bleeds into the brain.  An AVM is a cluster of 
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abnormally formed blood vessels that are comprised of snarled tangles of arteries and 
veins.   The presence of an AVM disrupts the cyclical process of blood flow.  It is 
estimated that approximately 300,000 Americans have AVM of the brain or spinal cord 
(National Institute of Neurological Disorders and Stroke [NINDS], 2015).  Any one of 
these vessels can rupture, also causing a hemorrhage into the brain.   
Hemorrhagic strokes are divided into two subtypes: intracerebral hemorrhage 
(ICH) and subarachnoid hemorrhage (SAH).  ICH results when the bleeding occurs 
inside the brain.  ICH accounts for 10% of all strokes.  SAH results when the bleeding is 
in the subarachnoid space between the cerebrum and the arachnoid mater.  SAH accounts 
for 3% of all strokes (Mozaffarian et al., 2015).  
Genetic Underpinning 
Understanding the underlying structural cause of blood vessel 
construction/destruction is an important aspect of understanding hemorrhagic stroke.  
Blood vessels consist of three layers: tunica intima, tunica media, and tunica externa.  
The tunica intima is the innermost layer of the blood vessel.  It is the only part of the 
vessel that is in contact with the blood.  It is comprised of simple squamous epithelium 
called endothelium.  Because of its extreme smoothness and normal chemical 
composition, the tunica intima prevents abnormal blood clotting by preventing the 
adhesion of platelets.  The endothelium of blood vessels also produces chemicals, such as 
nitric oxide (vasodilator—stimulates relaxation of the smooth muscle) and the peptide 
endothelin (vasoconstrictor—contraction of the smooth muscle) that affect blood 
pressure.  The middle layer, tunica media, is made of smooth muscle and elastic 
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connective tissue.  These tissues are involved in the maintenance of normal blood 
pressure, especially diastolic blood pressure.  The smooth muscle in this layer is affected 
by the chemicals produced by the endothelium.  The outermost layer, tunica externa, is 
made of fibrous connective tissue, which makes it very strong (Scanlon & Sanders, 
2011).  An abnormal protein or an abnormal amount of certain normal proteins in the 
blood can cause blood vessels to become abnormally formed or weakened, thus 
compromising blood vessel integrity.  
One gene associated with blood vessel integrity is the cerebral cavernous 
malformation (CCM) gene, which codes for the malcavernin protein.  This protein is 
involved in angiogenesis, which is the process in which new blood vessels form.  It 
strengthens the interactions between cells that form blood vessels and limits leakage from 
the vessel (NLM, 2016).  Even minor deficits in the CCM proteins or in their effectors 
can trigger a hemorrhagic stroke (Gore et al., 2008).  There have been three CCM genes 
identified in heritable disorders: CCM1/KRIT1 (Laberge, Labauge, Maréchal, Maciazek, 
& Tournier-Lasserve, 1999) CCM2/melcavernin (Denier et al., 2004), and 
CCM3/programmed cell death 10 (PDCD10) (Bergametti et al., 2005).  In humans, 
mutations in any one of these genes cause an autosomal dominant genetic ICH disorder 
characterized by CCM.  
Gore et al. (2008) investigated the interaction between CCM pathway genes and 
hemorrhagic stroke using zebrafish embryos and found that a combined minor reduction 
in the expression of multiple CCM pathway genes can precipitate hemorrhagic stroke. 
The rap1a gene is expressed normally during early development, but rap1b gene, a gene 
 
15 
 
implicated in the CCM pathway in endothelial cells, shows vascular-enriched expression. 
The rap1b gene encodes a RAS GTPase effector protein for CCM1/KRIT1.  It helps 
regulate cell adhesion, growth, and differentiation.  It also plays a role in regulating 
outside-in signaling platelets (NCBI RAP1B, 2016) and is a crucial player in the CCM 
pathway.  
Gore and colleagues (2008) designed a morpholino oligonucleotide experiment to 
knockdown rap1b.  During a knockdown experiment, a specific substance, such as an 
oligonucleotide with sequence complementary to an active gene or its mRNA transcript, 
is integrated with a specific gene to interfere with the expression of that gene.  
Researchers targeted either the ATG initiator codon or the second exon-intron boundary 
to interfere with rap1b translation or splicing.  After injecting the zebrafish embryos with 
the altered gene, and within 48 hours of fertilization, more than 70% developed ICH. 
Most hemorrhage foci were localized in, and around, the hindbrain ventricle.  There was 
also a left-side bias, with 62% of hindbrain hemorrhages occurring on the left side.  There 
were no deficits in proper patterning of nervous system, endothelial specification, or 
arterial-venous differentiation.  The specificity of the observed phenotype effects of 
rap1b knockout were further verified by co-injection of synthetic human Rap1b mRNA 
with zebrafish rap1b morpholino.  Two days post fertilization, 44% of co-injected 
embryos manifested cranial hemorrhages compared with 74% of embryos injected with 
rap1b ATG morholino alone.  These results indicate that rap1b morpholinos target rap1b 
and specifically knock out its function and suggest that human and zebrafish Rap1b 
proteins have a conserved function.   
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To determine if rap1b is specifically required in endothelial cells for maintenance 
of vascular integrity, researchers carried out a rescue experiment.  Rescue experiments 
are used to determine if the results from the knockdown experiment are the result of the 
gene or due to other effects not identified.  Researchers used zebrafish fli1 promotor to 
drive endothelial expression of human rap1b.  They co-injected a fli1:hRap1b DNA 
construct together with the zebra fish rap1b morpholino.  Prior to injection, cranial 
hemorrhage was 74%.  After injection, cranial hemorrhage was decreased to 30%.  These 
results indicate that rap1b function is required in endothelial cells for vascular integrity.  
Any change in the expression of rap1b increases the likelihood of ICH.  
Other genes associated with the structural integrity of blood vessels are COL4A1 
and COL4A2 (Gould et al., 2006; Jeanne et al., 2015).  COL4A1 and COL4A1 are 
located on the long arm of chromosome 13 at position 34.  Together, they are the most 
abundant and prevalent proteins in basement membranes, including those in the cerebral 
vasculature.  Basement membranes are a composite of several large glycoproteins and 
form an organized scaffold to provide structural support to the tissue and also offer 
functional input to modulate cellular function (LeBleu, MacDonald, & Kalluri, 2007). 
COL4A1 and COL4A2 provide strength to the basement membrane and also participate 
in dynamic biological process through interactions with growth factors and cell receptors, 
including bridging cell-to-cell or cell-to-extracellular matrix (NLM, 2016).  When 
mutations occur in COL4A1, small-vessel disease can result.  Gould et al. (2006) 
identified mutations in COL4A1 in mice with porencephaly, a rare genetic disorder in 
which fluid-filled cysts and cavities develop on the surface of the brain that can be the 
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result of hemorrhages.  Researchers found that all heterozygous mutant pups had cerebral 
hemorrhage, and approximately 50% died on the day of birth.  Next, researchers repeated 
the experiment, but this time, half of the pups were delivered surgically instead of 
naturally.  Of the surgically delivered mutant pups, none had severe hemorrhage.  These 
results suggest that COL4A1 may predispose mice to vascular fragility and act with birth 
trauma to cause cerebral hemorrhage.  For adult mice, a higher rate of death was seen 
among mutants compared to their control littermates with a significant number having 
SAH.  In addition to having hemorrhagic stroke as an outcome for mutations of COL4A1, 
researchers also found retinal vascular tortuosity, glomerular basement membrane, and 
microalbuminuria in mice.  These often occur in some families with small-vessel disease 
(Vahedi et al., 2007).  
In a later study, Jeanne and colleagues (2015) examined variants in COL4A1 and 
COL4A2 in mice and found that intracellular accumulation of mutant collagen in 
vascular endothelial cells and pericytes was a key triggering factor of ICH.  Researchers 
also determined that surgically delivered pups, as previously discussed by Gould and 
colleagues (2008), along with tamoxifen injections during pregnancy resulted in less ICH 
than non-treated, naturally born mice.  Another interesting outcome of this study was that 
physical exertion increased ICH, and anticoagulant administration provoked fatal 
hemorrhages within just 7 days of use.  These results demonstrate an association between 
hemorrhagic stroke and COL4A1 and COL4A2 in mice, as well as suggest a detrimental 
interaction with environment.  The interaction between gene (COL4A1 and COL4A2) 
and environment (increased exercise) is quite interesting as it pertains to hemorrhagic 
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stroke.  Historically, increased exercise has been associated with decreased stroke risk 
(Lee, Hennekens, Kerger, Buring, & Manson, 1998), but this study suggests that 
excessive exercise for those with mutations of the COL4A1 gene could be detrimental.  
Biological Risk Factors 
The risk factors for hemorrhagic stroke are not clearly defined.  Several biological 
risk factors, such as race, ethnicity (Broderick, Brott, Tomsick, Huster, & Miller, 1992; 
Howard et al., 2013), and high blood pressure (Howard et al., 2013; Matsukawa et al., 
2012; Sturgeon et al., 2007), are historically associated with hemorrhagic stroke.  Other 
factors, such as diabetes mellitus (Howard et al., 2013; Kissela et al., 2002; Woo et al., 
2002) and high cholesterol (Sturgeon, et al., 2007; Wieberdink et al., 2011) are not as 
clearly defined but may be precipitating factors.  
Age, Race, Ethnicity and Sex 
 African-Americans have a higher incidence of hemorrhagic stroke when 
compared to Hispanic and non-Hispanic White populations (Broderick et al., 1992; 
Howard et al., 2013).  Broderick and colleagues (1992) found that Blacks have a greater 
risk of SAH than Whites regardless of age, with the highest incidence seen in individuals 
54 years and younger.  Similarly, ICH was 4 times more likely in ages under 54 years for 
Blacks compared to Whites; however, unlike SAH, the risk at 75 years and older level off 
to a 25% difference between Whites and Blacks suggesting that advancing age is more 
important as a risk factor for ICH than SAH.  
 In a later study, Sturgeon et al. (2007) found that increasing age and African-
American ethnicity were risk factors for ICH.  In fact, an estimation of interaction of 
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ethnicity and age found at age 45, African-Americans had 5.8 times the ICH rate of 
Whites.  The relative rate decreased to 1.7 by age 65 and to 0.94 by age 75.  
 Hispanics are another minority population with a higher risk of hemorrhagic 
stroke (Morgenstern et al., 2004).  As part of the Brain Attack Surveillance in Corpus 
Christi (BASIC) project, Morgenstern and colleagues (2004) completed a study 
comparing the incidence of ICH and SAH in Mexican-American, Blacks, and non-
Hispanic whites.  Researchers found Hispanics have a higher incidence of hemorrhagic 
stroke than non-Hispanic Whites but lower than Blacks.  In addition, investigators found 
an increased risk of ICH regardless of age in Mexican Americans.  Young Mexican-
Americans aged 45-59 years had a three-fold increased risk of ICH compared with non-
Hispanic Whites.  Furthermore, Mexican-Americans were 1.5 times more likely to have 
SAH than non-Hispanic Whites.  From 1995 to 1998, age standardized mortality rates for 
SAH and ICH were higher among Blacks than Whites.  In an earlier study, Ayala et al. 
(2001) found that all minority populations, including Black, Asian/Pacific, and Hispanic, 
had higher mortality rates than Whites.  Interestingly, regardless of race and ethnicity, the 
risk ratio for hemorrhagic stroke was higher than the risk ratio for ischemic stroke in the 
25-44 and 45-64 age groups; however, for the ≥ 65 group, numbers were higher for 
ischemic stroke. Researchers suggested that differences in death rates between races and 
ethnic groups were possibly attributed to several factors including socioeconomic status, 
greater severity of disease, and poor survival at younger ages.  In addition, researchers 
suggested that variations in risk factors such as; obesity, uncontrolled high blood 
pressure, inactivity, poor nutrition, diabetes, and cigarette smoking attributed to higher 
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death rates. Other affecting factors such as a lack of access to medical care and a lack of 
knowledge about early warning signs of stroke can also impact a patient’s death rate.   
Generally, males have a higher incidence rate of hemorrhagic stroke.  Howard and 
colleagues (2013) found that men were significantly more likely to have ICH than 
females.  However, Appelros and colleagues (2009) completed a systematic review 
comparing incidence rates of hemorrhagic stroke among males and females and found 
that although ICH were higher among men, the rate of SAH was higher, although not 
statistically significant, among women.  
High Blood Pressure/Hypertension 
 High blood pressure (BP) is the best documented risk factor for hemorrhagic 
stroke.  According to the National Institutes of Health (2015) fact sheet, one in three 
adults in the United States have hypertension (systolic BP ≥ 140 mmHg or diastolic BP ≥ 
90 mmHg).  The prevalence of hypertension increases with age and is similar among men 
and women.  7.3% of adults aged 18 – 39, 32.2% of adults aged 40 – 59, and 64.9% of 
adults 60 years and older have hypertension. Men have a higher prevalence of 
hypertension than women among adults aged 18 – 39 (8.4% compared with 6.1%, 
respectively) and aged 40 – 59 (34.6% compared with 29.9%, respectively), but there is 
no significant difference of hypertension among men and women aged 60 and over 
(63.1% compared with 66.5%, respectively) (Yoon, Fryar & Carroll, 2015).  Blood 
pressure is influenced by three biological factors—how fast the heart is beating, how 
open and flexible the arteries are, and how much blood is pumping through the blood 
vessels (Chadha et al., 2012).  Blood pressure is measured by determining the systolic 
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and diastolic pressure.  Systolic BP is the measure of the arteries when the heart beats, 
and the diastolic BP measures the pressure in the arteries between heartbeats.  
Sturgeon and colleagues (2007) found that ICH increased most dramatically with 
increasing hypertension state.  For example, from Stage I hypertension, systolic BP 140 
to 159 mm Hg or diastolic BP 90 to 99 mm Hg, to Stage II, systolic BP 160 mm Hg to 
179 mm Hg, the relative rates of ICH doubled.  From Stage II to Stage III, systolic BP 
≥160 mm Hg or diastolic BP ≥110 mm Hg, relative rates doubled again, indicating that 
higher BP rates increase the risk of ICH.  
 Howard and colleagues (2013) found similar results.  For every 10 mm Hg higher 
difference in systolic BP, there was a 24% increase of ICH.  In addition, the use of 
warfarin increased the risk of ICH more than three times.  Warfarin is an anticoagulant 
that is often prescribed after an ischemic stroke or myocardial infarct to decrease the 
clotting tendency of blood.  It has been shown to increase prevalence of ICH and is 
related to increased mortality rates (Rosand, Eckman, Knudsen, Singer & Greenberg, 
2004).  Surprisingly, no association with hypertension status overall was detected, 
indicating higher systolic BP levels are a better indicator for risk of ICH than 
hypertensive status alone.  
An important gene in regulation blood pressure is the angiotensin converting 
enzyme (ACE) gene.  ACE helps regulate blood pressure and balance fluids and salts in 
the body.  It plays a vital role in the development of hypertension by cutting a protein 
called angiotensin I.  ACE converts this protein to angiotensin II.  Angiotensin II causes 
blood vessels to narrow, which results in increased blood pressure (NLM, 2016).  Higher 
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ACE activity leads to higher amounts of vasoconstrictor angiotensin II, which results in 
smooth muscle arteriolar proliferation, death of smooth muscle cell walls, and collagen 
deposition (Daemen et al., 1991; Fleming, 2006).  
 Das and colleagues (2015) compared the ACE genotypes and allelic frequencies 
in an Indian based population with a first time hemorrhagic stroke (n = 200) to an age and 
sex matched healthy control group (n = 200).  Researchers also compared other biological 
and environmental risk factors between groups.  The frequency of the DD genotype, as 
well as D allele was higher among the hemorrhagic group as compared to the controls. 
The DD genotype and D allele associated significantly with the disease using dominant, 
recessive, and co-dominant genotype models.  Unfortunately, this study did not report on 
the use of ACE inhibitors.  ACE inhibitors relax blood vessels and essentially lower 
blood pressure.  Nevertheless, this study suggests that there is a possible role of D allele 
in predisposing individuals to hemorrhagic stroke.  Interestingly, only 5% of participants 
had a family history of stroke, but 34% had a family history of hypertension.  This 
suggests that a family history of hypertension may play a more important role in 
hemorrhagic stroke for those individuals with the DD genotype than a history of 
hemorrhagic stroke alone.  In addition, there was no significant difference between the 
group’s total cholesterol level or HDL levels.  LDLs were not reported in the study. 
Triglyceride levels and a diagnosis of diabetes mellitus were significantly higher in the 
hemorrhagic stroke group.  Smoking and alcohol use were significantly higher in the 
hemorrhagic stroke group, as well.  Unfortunately, these environmental factors were not 
clearly defined.  
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Sanders and colleagues (2006) studied menstrual cycles of 23 healthy females (12 
with dominant insertion (II) variant of the ACE genotype and 11 with dominant deletion 
(DD) variant of the ACE genotype) and found that ACE activity did not vary overall 
regardless of genotype.  Interestingly, ACE activity throughout the cycle was 
significantly lower in those participants with II (21.4 +/- 4.1), compared to DD (32.4 +/- 
8.4).  Unfortunately, the researchers did not include information about blood pressure 
levels, thus elevated blood pressure in the DD genotype could not be verified.  
Several studies have examined the association of the DD genotype in other 
populations.  Sun and colleagues (2013) completed a meta-analysis on 805 participants 
with ICH and 1,641 controls from eight case controlled studies.  Asian and Caucasian 
populations were included in the review.  Results indicate that the DD homozygote 
carriers among Asians are more prone to increased risk of ICH than their Caucasian 
counterparts.  Researchers found a 58% increase in the susceptibility to ICH in the 
dominant genetic model of the polymorphic variant I/D. In another study of a Spanish-
Mediterranean population, researchers found that the DD genotype of the ACE gene was 
the strongest independent predictor of hypertension in individuals with diabetes mellitus 
(Martínez et al., 2000).   
Although hypertension can be associated with the ACE gene and has a strong 
familial association, its cause can also be linked to environmental factors, such as lack of 
exercise, poor diet, and smoking (Alderman, 2000; Ishikawa-Takata, Ohta, & Tanaka, 
2003). Some studies suggest that modifying the environmental risk factors may lower 
blood pressure.  For example, Ishikawa-Takata et al. (2003) found that exercising as little 
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as 30 to 60 minutes a week significantly lowered blood pressure.  Alderman (2000) found 
that by lowering salt intake, the risk for high blood pressure can be reduced.        
Cholesterol 
 High serum total cholesterol (greater than or equal to 240 mg/dL) is present in 
12.1% of adults age 20 years and over within the general population (National Center for 
Health Statistics, 2016). The association between high cholesterol and hemorrhagic 
stroke is inconclusive. Sturgeon and colleagues (2007) studied risk factors associated 
with ICH.  They did not find overall cholesterol to be significantly associated with ICH; 
interestingly, the researchers did find that low LDL was a significant risk factor for ICH.  
In a later study by Wieberdink and colleagues (2011), decreasing levels of total serum 
cholesterol were associated with an increased risk of ICH, but LDLs were not associated 
with the risk of ICH.  On the other hand, Kim and colleagues (2004) did not find a 
significant association between hemorrhagic stroke and high total cholesterol, although 
this study consisted of females only with the majority of strokes consisting of SAH.  It 
did not assess differences between ICH and SAH and high cholesterol, so a difference 
could possibly be found. Because high LDL cholesterol can leave fatty deposits within 
the lining of the arteries (NIH, National Institutes on Aging, 2005), it is possible that 
having low LDL could cause thinning areas along the artery wall, thus increasing the risk 
for ICH (Konishi et al., 1993).  
In recent years, the apolipoprotein E (APOE) gene has also been studied to 
determine if it is associated with hemorrhagic stroke.  The APOE gene is located on the 
long arm of chromosome 19.  It codes for 299-amino acid protein (apoE), which is a 
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polymorphic glycoprotein involved in cholesterol transport and cell membrane 
maintenance and repair (Mahley, 1988).  ApoE protein is involved in the elimination of 
excess cholesterol from the brain.  It is regulated by the liver X receptors, which are 
important regulators of cholesterol, fatty acid, and glucose homeostasis (Zerbinatti, 
2009).  Mutations of APOE are associated with higher levels of plasma cholesterol levels 
and accelerated coronary artery disease.  APOE has three common alleles (e.g., ԑ2, ԑ3, 
ԑ4), and each person has two alleles that together compose that person’s APOE genotype 
(e.g. ԑ2/ԑ3, ԑ3/ԑ3, ԑ3/ԑ4) (Mahley, 1988).  The APOE ԑ2 variant is associated with slower 
cholesterol metabolism, which results in lower cholesterol.  In contrast, the APOE ԑ4 
variant is associated with faster cholesterol metabolism, resulting in a higher cholesterol 
level (Mahley, 1988).  In a meta-analysis of 11 case-control studies with 1,238 ICH cases 
and 3,575 control cases, Zhang et al. (2014) found that there was a significantly higher 
frequency of APOE ԑ4 allele in the ICH cases.  In addition, researchers found that Asians 
and Caucasians had a significantly higher frequency of APOE ԑ4.  
A mutation of the apoE protein affects the regulating mechanism.  If there is a 
large amount of apoE protein, cholesterol level will increase.  Approximately 6.2% of 
adults ≥ 20 years of age have undiagnosed hypercholesterolemia, defined as a total 
cholesterol level ≥ 240 mg/dL (Mozaffarian, et al., 2015).  Zerbinatti (2009) injected rats 
with apoE and found significant levels of cholesterol in the cerebral spinal fluid as early 
as 3 days after injection.  Although there appears to be a link between ICH and APOE 
gene and between apoE protein and cholesterol levels, the association between ICH and 
cholesterol levels is inconclusive.   
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Diabetes Mellitus and Hemorrhagic Stroke 
 Although diabetes mellitus is highly correlated with ischemic stroke (Jerrad-
Dunne et al., 2003; Jood et al., 2005), it is not often associated with hemorrhagic stroke. 
Indeed, most studies do not find an association between diabetes mellitus and 
hemorrhagic stroke (Howard et al. 2013; Kissela et al., 2002; Matsukawa et al., 2012); 
however, one study (Woo et al., 2002) did find a slight association between ICH and 
diabetes mellitus although it was not significant.  Diabetes mellitus is associated with 
hypertension and therefore may be a precipitating factor for hemorrhagic stroke.  
Several gene variations are associated with diabetes mellitus (i.e., HLA-DRB1, 
HLA-DQB1, and HLA-DQA1) (NML); however, none of these gene variants have been 
shown to have an association with hemorrhagic stroke.  Diabetes Mellitus results from 
defects in insulin secretion, insulin action, or both.  It has been associated with blood 
vessel, kidney, and heart damage (American Diabetes Association, 2009).  Some studies 
suggest that diabetes mellitus is associated with hemorrhagic stroke, but others do not. 
Because diabetes mellitus is associated with blood vessel damage and kidney damage, 
and both of these are associated with hemorrhagic stroke (Mozaffarian et al., 2015), it is 
possible that there may be a stronger association with hemorrhagic stroke. 
Environmental Risk Factors 
Smoking and Hemorrhagic Stroke  
Several modifiable risk factors are associated with ICH and SAH, including 
cigarette smoking, alcohol consumption, and stress.  Smoking has a strong association 
with hemorrhagic stroke and is one of the most preventable causes of a variety of 
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diseases (Centers for Disease Control and Prevention [CDC], 2014).  When nicotine 
enters the bloodstream, it immediately stimulates the adrenal glands to release the 
hormone epinephrine.  Epinephrine stimulates the central nervous system and increases 
blood pressure, respiration, and heart rate (CDC, 2014).  In addition, cigarette smoking 
may have an adverse effect on lipid metabolism (beta blockers, diuretics) (Porkka & 
Ehnholm, 1996) due in part by free radical damage to the lipids (Miller, 1997).  
Brischetto, Connor, Connor, and Matarazzo (1983) proposed a mechanism to 
explain the link between smoking and changes in serum lipid and lipoprotein 
concentrations.  First, nicotine stimulates the release of adrenaline by the adrenal cortex, 
leading to the increased serum concentrations of free fatty acid observed in smokers.  
Next, free fatty acid is a well-known stimulant of hepatic secretion of very low LDL and 
hence higher triglyceride.  Triglycerides are a type of lipid stored in fat cells in the blood. 
Finally, HDL concentrations vary inversely with very low LDL concentrations in serum.  
Complementary to this mechanism is the finding that free fatty acid also stimulates 
hepatic synthesis and secretion of cholesterol.  
Alcohol Use and Hemorrhagic Stroke 
Another environmental risk factor associated with hemorrhagic stroke is alcohol 
consumption.  It is suspected that heavy alcohol use can stop the growth of new brain 
cells (NIH, 2004).  Klatsky, Armstrong, Friedman, and Sidney (2002) found no increased 
risk of hemorrhagic stroke among light or moderate drinkers of either sex or race but did 
find a slight increase in hemorrhagic stroke for individuals who were heavy drinkers (≥3 
drinks per day).  Interestingly, the relative risk, when compared by type of beverage, 
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showed no independent association to hemorrhagic stroke risk (wine = 1.02, liquor = 
1.06, and beer = 1.05).  It is unclear exactly how biological changes due to alcohol use 
are associated with hemorrhagic stroke.  
Psychosocial Stress 
According to Centre for Studies on Human Stress (2007), when an individual 
interprets a situation as being stressful, it triggers the activation of the hypothalamic-
pituitary-adrenal (HPA) axis whereby neurons in the hypothalamus release corticotropin-
releasing hormone (CRH).  The release of CRH triggers the subsequent secretion and 
release of adrenocorticotropin (ACTH) from the pituitary gland, which travels in the 
blood and reaches the adrenal glands, which triggers secretion of the stress hormones 
cortisol, epinephrine and norepinephrine.  Several studies have shown an association 
between psychosocial stress and hemorrhagic stroke although the definition differs.  For 
example, O’Donnell and colleagues (2010) found psychosocial stress, defined as a 
combined measure of general stress at home and in the workplace, to be significantly 
associated with ICH.  Henderson and colleagues (2013) found distress was an 
analytically derived composite measure of depressive symptoms, perceived stress, 
neuroticism, and life dissatisfaction.  For each 1-SD increase in distress, there was 1.47 
increase in stroke mortality and 1.18 increase in stroke incident.  O’Donnell and 
colleagues (2010) found psychosocial stress, defined as a combined measure of general 
stress at home and in the workplace; depression: feeling sad, blue or depressed for 2 or 
more consecutive weeks during past 12 months, significantly associated with ICH.  
Defining psychosocial stress is a complex concept.  It considers personal and professional 
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aspects and varies from person to person based on perception. The same biological 
reaction to stress is consistent within all human beings. It is instead, the person’s 
perception and management of that stress that is individualistic to each situation. Thus 
making human beings reaction to stress idiosyncratic in nature (Centre for Studies on 
Human Stress, 2007).  Unfortunately, no known studies on cortisol levels prior to stroke 
exist.  Without these studies, there can be only speculation that increased cortisol level as 
the result of stress is an increased risk factor for hemorrhagic stroke.  
Risk Factors by Location in the Brain 
ICH occurs more frequently than SAH and has poorer outcomes.  Of patients who 
survive, only 28%-35% are independent at 3 months after damage (Woo et al., 2002).  
Some studies suggest that risk factors for ICH and SAH vary based on location and that 
this plays a role in prevalence (Flaherty et al., 2005; Martini et al., 2012; Nieuwkamp, 
Wilde, Wermer, Algra, & Rinkel, 2014).   
Location of ICH Within the Brain 
ICH can be divided into two primary locations, lobar and nonlobar (basal ganglia, 
thalamus, brainstem, cerebellum, or periventricular white matter).  Martini and colleagues 
(2012) studied 597 Blacks and Whites with a first time history of ICH and found that 
regardless of location, all ICH were more likely to be associated with hypertension, 
current warfarin use, having a first-degree relative with ICH, having a personal history of 
ischemic stroke, having less than high school education, and having the APOE ԑ2 or ԑ4 
genotype.  When compared by different locations, risk factors for subjects with lobar 
damage included warfarin use, prior history of ischemic stroke, less than a high school 
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education, and the APOE ԑ2 or ԑ4 genotype.  For subjects with nonlobar ICH, risk factors 
included history of hypertension, warfarin use, first-degree relative with ICH, prior 
history of ischemic stroke, and less than a high school education.  Roughly 10% of 
subjects had a history of ischemic stroke and about 15% warfarin use.  Had researchers 
excluded these two groups, the study could have been a little more compelling.  
Interestingly, Blacks with ICH, regardless of location, were six times more likely to have 
hypertension than the control group, and Whites with ICH, regardless of location, were 
two times more likely to have hypertension compared to the control group.  Nevertheless, 
the major difference between risk factors when compared between the two locations was 
that hypertension and high cholesterol were associated with nonlobar ICH, whereas 
APOE ԑ2 or ԑ4 genotype was associated with lobar ICH.  This suggests that there are 
different pathophysiological processes for ICH based on location.  In addition, this 
suggests that there may be a protective association of hypercholesterolemia that varies by 
hemorrhage location.  
APOE ԑ2 or ԑ4 genotype has been associated with lobar ICH in other studies as 
well, and it appears to play a role in the pathogenesis of amyloid angiopathy (Biffi et al., 
2010; Charidimou et al., 2015; Woo et al., 2004; Zhang et al., 2014).  Cerebral amyloid 
angiopathy is the result of the deposition of an amyloidogenic protein in cortical and 
leptomeningeal vessels.  The accumulation of amyloid correlates with loss of smooth 
muscle cells that are found within the walls of blood vessels (Rensink et al., 2003). 
Damage to smooth muscle cells can result in thinning of the cell wall, which can result in 
hemorrhage (Frösen, 2014).  
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Charidimou and colleagues (2015) studied cerebral amyloid angiopathy in 
patients with and without lobar ICH.  Researchers found that the subjects with cerebral 
amyloid angiopathy presenting with lobar ICH were more likely to have the APOE ԑ2 
genotype, but in non-hemorrhagic cerebral amyloid angiopathy cases, APOE ԑ4 was 
enriched.  This suggests that the APOE ɛ4 genotype may be a protectant against 
hemorrhage whereas APOE ɛ2 increases the risk of hemorrhage.  
Location of SAH in the Brain 
 SAH occur less frequently than ICH.  Incidence and outcome are based on 
artherogenic risk factors (i.e., hypertension, smoking, etc.) and the size and location of 
the aneurysm.  Only about 50% of those who experience a SAH survive (van Gijn, Kerr, 
& Rinkel, 2007).  Familial aggregation of SAH occurs in 6% to 9% of SAH cases, and 
those with familial SAH have worse outcome than those cases that are sporadic 
(Bromberg et al., 1995).  
 Nieuwkamp and colleagues (2014) studied the clinical and radiological 
heterogeneity of aneurysmal SAH based on associated risk factors.  Subjects were 
divided into two groups: those with artherogenic risk factors (hypertension and smoking) 
(n = 113) and those without (n = 29).  Even though researchers purposely included only 
young adults (ages 18-40), and an overwhelming large percentage (nearly 80%) were 
either diagnosed with hypertension and/or were smokers, resulting in a small sample size 
of those without artherogenic risk factors.  Nevertheless, researchers found that the 
middle cerebral artery was the site of aneurysm for most SAH cases regardless of group. 
Interestingly, subjects with artherogenic risk factors were less often women.  In addition, 
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the atherogenic risk factor group had more often-larger aneurysms, multiple aneurysms, 
and a poorer outcome.  
Research Question and Rationale 
 The causes of hemorrhagic strokes are multifactorial but appear to have a strong 
familial link.  The low incidence and high mortality rates make it difficult to determine a 
specific genetic source.  However, several genes are associated with hemorrhagic stroke 
and it is the documented biological risk factors that may help researchers determine if 
there is a specific gene or group of genes that increases the risk of hemorrhagic stroke 
within families.  
 Each gene has its own purpose and plays an important role in maintaining balance 
within the vascular system. The CCM pathway genes and COL4A1/COL4A2 genes both 
relate to cell integrity. Mutations in either of these gene groups significantly increase the 
risk of hemorrhages.  For COL4A1/COL4A2, increased blood flow, as in exercising or 
during the stress of natural birth process, increases the risk even more, demonstrating that 
the interaction between genes and environment is an important component of disease 
outcome.  Hormone replacement therapy or having a first pregnancy at an older age is 
associated with decreased risk of SAH, supporting a yet undetermined association 
between hormones and acquisition of hemorrhagic stroke.   
 Hypertension is a primary risk factor for hemorrhagic stroke.  Higher stages of 
hypertension significantly increase the risk of ICH.  As blood pressure builds, it can 
cause already weakened blood vessels to rupture resulting in a hemorrhagic stroke.  The 
ACE gene is part of the renin-angiotensin-aldosterone system (RAAS) and is important in 
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the regulation of blood pressure.  RAAS increases renin production.  Renin release is 
triggered when blood pressure is low, when there is sympathetic nerve cell action (i.e., 
fight or flight response), or when salt levels are low.  A dominant ACE genotype is 
significantly associated with hypertension, as well as ICH and can result in smooth 
muscle cell death and collagen deposition.  
The association between cholesterol levels and hemorrhagic stroke is not as clear 
as the relationship between hypertension and hemorrhagic stroke.  ApoE is one of the key 
lipoproteins of lipoprotein complexes that regulate the metabolism of lipids by directing 
their transport, delivery, and distribution from one tissue or cell type to another through 
apoE receptors and proteins associated with lipid transfer and lipolysis.  Higher levels of 
cholesterol are associated with higher levels of apoE protein.  The APOE ԑ4 variant is 
associated with faster cholesterol metabolism resulting in higher cholesterol levels; 
whereas, the APOE ɛ2 variant is associated with slower cholesterol metabolism resulting 
in lower cholesterol level.  Both APOE ɛ4 and ɛ2 have been associated with lobar ICH 
and play a role in the pathogenesis of amyloid angiopathy.   
Limited incidences of hemorrhagic stroke make researching risk factors 
challenging.  Identifying a family with a strong history of hemorrhagic stroke is the first 
step in the research process.  With ASHA’s position statement on the importance of 
prevention of communication problems, it is the responsibility of those in the field of 
speech-language pathology to expand the traditional role of identification and treatment 
of communication disorders to include efforts to eliminate the underlying cause of those 
disorders.  Because communication disorders result from hemorrhagic stroke, the best 
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way to treat them is to eliminate the source.  Therefore, determining the risks of 
hemorrhagic stroke and preventing them is the first place to start.  It is unlikely that there 
is one gene that guarantees an individual will acquire a hemorrhagic stroke; instead, it is 
more likely that several genes interact with each other and the environment that would 
result in hemorrhagic stroke.  Thus, it is expected that there will be differences in the 
environmental and biological risk factors within families with a history of hemorrhagic 
stroke and between families with hemorrhagic stroke.   
This study is designed to answer the following research questions related to 
familial hemorrhagic stroke: 
Question 1: What are the similarities and differences of the biological risk factors 
associated with hemorrhagic stroke, such as hypertension, diabetes, and/or 
hypercholesterolemia within and between families with hemorrhagic stroke?  
Question 2: What are the similarities and differences of the environmental factors 
associated with hemorrhagic stroke, such as exercise, alcohol consumption, 
mediation use, etc. within and between families affected by hemorrhagic stroke? 
Question 3: Are there differences between the location of hemorrhagic stroke 
between and within families?  
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CHAPTER III 
 
METHODS 
 
 
The purpose of this study was to determine the risk factors associated with 
hemorrhagic stroke within families with a history of hemorrhagic stroke and between 
families with a history of hemorrhagic stroke.  The risk factors of hemorrhagic stroke 
were determined by administration of a family medical and social history questionnaire. 
In addition, participants completed the Health Promoting Lifestyle Profile II (HPLPII) 
and the Perceived Stress Scale (PSS). The rationale for use of these participants is that 
because hemorrhagic strokes aggregate within families, there is a greater chance that a 
genetic commonality can be found within the same family and possibly between families.  
Participants 
Participants were recruited through stroke support groups in the southeast, social 
media and Casa Colina Hospital and Medical Center in Pomona, California.   Individuals 
who had a hemorrhagic stroke at age 65 years or younger and had at least one other 
family member with a hemorrhagic stroke at 65 years or younger were invited to 
participate in the study.  First- and second-degree relatives of the person with 
hemorrhagic stroke were also invited to participate in the study.   
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Inclusion Criteria 
1. Hemorrhagic stroke at the age of 65 or younger 
2. At least one first or second degree relative who had a hemorrhagic stroke at the 
age of 65 or younger 
3. Understands and reads English well enough to read and answer questionnaire 
questions  
Exclusion Criteria 
1. Presence of other neurological or neurodegenerative disease 
Data Collection Procedures 
The current study was approved by the Institutional Review Board at the 
University of North Carolina at Greensboro and Institutional Review Board at Casa 
Colina Hospital and Centers for Healthcare.  An informed consent was secured from each 
participant before enrolling in the study.  
Recruitment flyers were emailed or mailed to 14 stroke support group facilitators 
in the southeast.  Two stroke support group facilitators requested additional information, 
1 facilitator reported no stroke support group members with a hemorrhagic stroke and 
declined to assist with recruitment, and no information was obtained from the remaining 
11 stroke support group facilitators. Flyers and emails were sent to speech-language 
pathologist and physical therapist working at 4 hospitals and 4 universities and 
community colleges in the southeast. Information was also shared on social media 
(Facebook). Seven individuals initially contacted researchers for possible inclusion in the 
study. Initial interviews determined 3 of the individuals had an ischemic stroke rather 
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than a hemorrhagic stroke and were eliminated. The remaining 4 individuals had a 
hemorrhagic stroke or had a first or second degree relative with a hemorrhagic stroke and 
were asked to contact their first and second degree relatives to determine if family 
members would be willing to participate in the study. Four families were recruited for the 
study for a total of 14 individuals (8 with hemorrhagic stroke, 6 without hemorrhagic 
stroke). In addition, 2 individuals from Casa Colina were recruited and filled out initial 
questionnaires but researchers were not able to contact them for follow-up questions. 
Therefore, there was not sufficient data available to include them in the study.  
Family, Medical and Social History Questionnaire 
The purpose of administering a medical history and social questionnaire in this 
study was to establish personal and family history of hemorrhagic stroke as well as risk 
factors associated with hemorrhagic stroke. Participants were asked if they had a first or 
second degree blood relative who had a hemorrhagic stroke at or before the age of 65. 
Once identified, participants were asked at what age the family member had the 
hemorrhagic stroke and if the family member had a history of hypertension, high 
cholesterol, or diabetes. The medical history portion of the questionnaire asked specific 
questions about history of high blood pressure, high cholesterol, and diabetes. 
Participants without a hemorrhagic stroke were asked to obtain their blood pressure, 
cholesterol and blood glucose levels from their physician and share this information with 
researchers. Participants who had a hemorrhagic stroke were asked to obtain the same 
information with the addition of the location of their hemorrhage, blood pressure, 
cholesterol and blood glucose levels prior to their hemorrhagic stroke and share this 
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information with researchers. The social history portion of the questionnaire asked 
specific questions related to cigarette smoking, alcohol consumption, and exercise habits, 
as well stress level prior to the hemorrhagic stroke. Non-hemorrhagic stroke participants 
were asked the same questions as they pertain to their current history.  
Definitions 
High blood pressure was defined as systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 
mmHg based on current guidelines (James et al., 2014) or currently taking medication for 
high blood pressure (i.e., thiazide diuretics, angiotensin converting enzyme inhibitors, 
calcium blockers, beta blockers or angiotensin receptor blockers).  
High cholesterol was defined as blood cholesterol level ≥ 200 based on current 
guidelines (Stone et al., 2014) or currently taking medication to lower cholesterol levels, 
such as statins or cholesterol absorption inhibitors.  
Diabetes Mellitus was defined based on current guidelines of A1C ≥ 6.5, fasting 
plasma glucose ≥126 mg/dL (American Diabetes Association, 2012) or taking medication 
to lower blood glucose levels such as, insulin, biguanides, or meglitinides.   
High risk medications were defined as any medication that interferes with the 
blood’s ability to clot, such as anticoagulant and/or antiplatelet.   
Health Promoting Lifestyle Profile II 
The Health Promoting Lifestyle Profile II (HPLPII) (Walker, Sechrist, & Pender, 
1983) is a self-report questionnaire. It was administered to determine the health-
promoting lifestyle habits of participants. The HPLPII consists of 52 questions related to 
lifestyle habits and gives an overall health-promoting lifestyle score and six subscales: 
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health responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, 
and stress management. The options for the questions are given on a four-point Likert 
scale (“never” (1), “sometimes” (2), “often” (3), and “routinely” (4)) and asked the 
respondents to indicate how often they adopt specific health-promoting behaviors. Non-
hemorrhagic stroke participants were asked to answer each question based on their habits 
for the past 6 months. Participants with hemorrhagic stroke were asked to answer the 
same questions, to the best of their recollection, of their habits 6 months prior to their 
hemorrhagic stroke. Overall, the score for health-promoting lifestyle and behavioral 
aspects was calculated using the mean of responses for all 52 items and for each subscale 
(eight or nine items).   
Perceived Stress Scale  
The Perceived Stress Scale (PSS) (Cohen, Kamarck, Mermelstein,1983) is a self-
report measure of stress. It consists of 10 questions related to how individuals perceive 
their own stress in the past month. Participants with hemorrhagic stroke were asked to 
answer the questions, to the best of their knowledge, of their feelings or thoughts 
occurring one month prior to their hemorrhagic stroke. Non-hemorrhagic stroke 
participants were asked to respond to questions with events occurring in the last month. 
Responses: never, almost never, sometimes, fairly often, and very often were added 
together to determine an overall PSS score. Questions 1, 2, 3, 6, 9, and 10 were scored 0 
to 4, respectively. Questions 4, 5, 7, and 8 were scored 4-0, respectively. The PSS has a 
range of scores between 0 and 40 with higher scores indicating more perceived stress. 
Scores ranging from 0-13 would be considered low stress, 14-26 would be considered 
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moderate stress, and 27-40 would be considered high-perceived stress. Each person 
handles stress differently. One person may find the exact same event very stressful, 
another person may not find it stressful at all. The PSS allows participants to rate their 
own perceived stress.  
Data and Statistical Analyses 
This study had retrospective and prospective elements. That is, participants with 
hemorrhagic stroke were asked to recall environmental and medical information prior to 
their stroke, whereas, non-hemorrhagic stroke participants answered the same basic 
questions relevant to their current state.  Nonparametric statistical analysis was preformed 
to compare biological risk factors and environmental risk factors associated with 
hemorrhagic stroke within and between families with a history of hemorrhagic stroke and 
to measure the strength and direction of association that exists between variables where 
appropriate. Visual representation, such as pedigree charts, bar charts and scatter plots, 
were used for data comparison. All necessary statistic procedures were completed using 
IBM SPSS V.20 software, Armonk, NY. 
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CHAPTER IV  
RESULTS 
 
 
The aim of the study was to identify similarities and differences of the biological 
risk factors associated with hemorrhagic stroke, such as hypertension, diabetes mellitus, 
and/or high cholesterol, and environmental risk factors, such as exercise, alcohol 
consumption, smoking, and perceived stress within and between families with a history 
of hemorrhagic stroke. Health and family history questionnaires were obtained from 4 
families with a history of hemorrhagic stroke to determine if there were commonalities 
within the same family or among the different families. In addition, the HPLPII was 
administered which gave an overall total score and 6 subtest scores: health responsibility, 
physical activity, nutrition, spiritual growth, interpersonal relations, and stress 
management.  PSS was used to determine perceived stress.  
Participant demographics by family for gender, current age, age at time of 
hemorrhagic stroke, race and familial relationship are shown in Table 1.  
 
 
42 
 
Table 1. Participant Demographics  
Family Participant Relationship 
to Proband 
Sex Race Current 
Age 
Hemorrhagi
c Stroke 
(Y/N) 
Age at 
Hemorrhagic 
Stroke 
Family 
1 
P.M. (II 3) Proband 
F White 65 
Yes 55 
 G.M. (I 2)  Mother F White Deceased Yes  62 
 W.M. (III 
2)  
Daughter 
F White 50 
No  --- 
 S.M. (III 3)  Daughter F White 45 No --- 
Family 
2 
A.D. (II 1) Proband 
M White 73 
Yes 65 
 B.D. (III 1) Son F White 45 Yes 40 
 G.D. (III 2) Daughter F White 39 No --- 
 S.D. (III 3) Daughter F White 37 No --- 
Family 
3 
H.N. (III 1) Proband 
M White 62 
Yes 59 
 B.H. (II 4) Aunt F White 84 Yes 64 
Family 
4 
M.C (II 1) Proband 
F AA Deceased 
Yes 62 
 S.C. (III 2) Daughter F AA 49 No  --- 
 I.C. (III 3) Daughter F AA 48 Yes 41 
 T.C. (III 4) Daughter F AA 48 No --- 
 
 
Family History 
Family 1 
P.M. is participant II 3 on the pedigree shown in Figure 1. She is a 65-year-old 
white female who had a left frontal lobe hemorrhagic stroke at the age of 55. P.M. 
reported a history of hypertension and diabetes mellitus prior to her hemorrhagic stroke. 
She took medication for regulation of both. She did not take aspirin or any other 
anticoagulant medication. P.M. reported that she did not participate in strenuous exercise 
4 or more hours per week. She reported that she did have general stress; she did not 
smoke but did drink alcohol (1-30 drinks per month) prior to her stroke. She had 4 
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children. One son died at the age of 22 in a car accident, one son, currently 53 years of 
age with a history of hypertension, did not participate in the study. P.M.’s oldest 
daughter, W.M. is participant III 2 on the pedigree in Figure 1. W.M. is a 50-year old 
female who reported no history of hypertension, diabetes mellitus or high cholesterol. 
She did not smoke cigarettes but did drink alcohol (1-30 drinks a month). She reported no 
general stress. W.M.’s BMI is 21.8. P.M.’s youngest daughter, S.M., participant III 3 on 
the pedigree in Figure 1, reported a recent diagnosis of hypertension, but no history of 
diabetes mellitus or high cholesterol. She did not smoke cigarettes, drink alcohol or do 
moderate or strenuous exercise 4 hours per week or more. She did report general stress.  
P.M.’s mother, G.M., participant I 2 on the pedigree shown in Figure 1, had a 
hemorrhagic stroke at the age of 62 that resulted in death. G.M. had a history of 
hypertension, diabetes and high cholesterol. Her BMI was 26.5. She reportedly had a 
history of hypertension, diabetes mellitus and high cholesterol. She did not smoke 
cigarettes, drink alcohol or exercise. She had 4 children (2 males, 2 females).  
P.M. had two older brothers who are deceased. Both brothers died prior to the age 
of 65, one with complications due to a heart transplant and the other from an unknown 
cause. She has one living sister age 62. No information was available about the sister.  
Family 2 
 A.D. is participant II 1 on the pedigree in Figure 2. She is a 73-year old female 
with right hemisphere frontal lobe hemorrhagic stroke at age 65. A.D. reported a history 
of hypertension and high cholesterol but not diabetes mellitus prior to her stroke. She 
took medication for both hypertension and high cholesterol as well as 350 mg baby 
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aspirin prior to her stroke. She reported that she did exercise, did not smoke cigarettes or 
drink alcohol prior to her stroke, but did have general stress prior to her stroke. Her BMI 
at the time of her stroke was 33.3. A.D. had a younger brother who died in his 60s of 
heart disease. Her mother died in her 80s of a stroke although she did not know the type 
(ischemic or hemorrhagic). Her father also died of a heart attack in his 70s. She has four 
children.  
 A.D.’s oldest son, B.D. is participant III 1 on the pedigree in Figure 2. B.D. had a 
right hemisphere, frontal lobe hemorrhagic stroke at the age of 40. A.D. did not go to the 
doctor regularly prior to his stroke and had no knowledge of his medical history. 
However, to his knowledge, he did not have hypertension, high cholesterol or diabetes 
mellitus. Currently, he has hypertension and takes medication for this. He did not report 
exercise or general stress prior to his stroke. He did drink alcohol (>30 drinks a month) 
and smoked cigarettes (>1 pack a day).  At the time of his stroke, B.D.’s BMI was 26.2. 
He has no children. 
 A.D.’s three other children were the progeny of a different father than B.D. and 
were therefore half-siblings to him. G.D., a 39-year old female, is the eldest daughter of 
A.D. She is participant III 2 on the pedigree in Figure 2. She reported no history of 
hypertension, high cholesterol or diabetes mellitus. She did not exercise. She did drink 
alcohol (1-30 month), did not smoke, and reported no general stress. G.D.’s BMI is 33.3. 
She has no children.  
 S.D. is participant III 3 on the pedigree in Figure 2. She is the youngest daughter 
of A.D. and half-sibling to B.D. and full sibling to G.D. S.D. reported a history of 
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hypertension and high cholesterol, but not diabetes mellitus. She did not exercise. She did 
drink alcohol (1-30 per month), and smoke cigarettes (>1 pack per day). She also 
reported general stress. S.D.’s BMI is 36.0. She has no children.  
A.D.’s 35-year old youngest son reportedly has hypertension but no other 
information was available.  
Family 3 
 Family 3 consisted of two participants. H.N. is participant III 1 on the pedigree in 
Figure 3. He is a 62-year-old white male who had a right hemisphere hemorrhagic stroke 
at the age of 59.  He reported episodic hypertension, not medicated, prior to his stroke. 
He reported no high cholesterol or diabetes mellitus prior to his stroke. He did participate 
in moderate or strenuous exercise 4 hours or more per week. He drank alcohol (1-30 
month). He did not smoke cigarettes. He reported general stress prior to his stroke. He 
had no children. According to H.N., both his maternal grandfather and great-grandfather 
had strokes at an early age. H.N.’s parents both have hypertension. His father has been 
taking blood pressure medication since he was in his mid-30s.  
B.H. is participant II 4 on the pedigree in Figure 3. She is the 84-year old paternal 
aunt to H.N. B.H. had a hemorrhagic stroke at the age of 64. She reported a history of 
hypertension, unmedicated prior to her stroke. She did not have diabetes mellitus or high 
cholesterol.  She did not exercise prior to her stroke. She did drink alcohol (1-30 per 
month) and did not smoke cigarettes. B.H. did not have any biological children. B.H. has 
father had an aneurysm in his brain at the age of 65 and died during surgery to repair it. 
Her mother died of cardiac arrest in her mid-70s.  
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Family 4  
M.C. is participant II 2 on the pedigree in Figure 4. M.C. was an African 
American female who had a hemorrhagic stroke at the age of 56. She died at the age of 
62 with breast cancer. According to M.C.’s daughters, S.C. and I.C., participants III 2 and 
III 3, respectively, M.C.  had a history of hypertension and high cholesterol but not 
diabetes mellitus prior to her stroke. She reportedly did not smoke cigarettes or drink 
alcohol. Her BMI was 22.7 at the time of her stroke. M.C. had 7 siblings all with a 
history of hypertension. M.C.’s mother, represented on the pedigree in Figure 4 as I 2, had 
a stroke at the age of 68 that resulted in death. M.C. had 4 daughters. The oldest three 
daughters participated in the study. Her youngest daughter, age 46, did not, but reportedly 
has hypertension.  
M.C.’s oldest daughter, S.C., is a 49-year-old with a history of hypertension and 
high cholesterol but not diabetes mellitus. She did not smoke. She did report that she did 
drink alcohol (1-30 drinks per month). S.C.’s BMI is 26.6. She has 3 children.  
I.C. had a right hemisphere hemorrhagic stroke at the age of 41. She had a history 
of hypertension and high cholesterol but not diabetes mellitus prior to her stroke. She did 
participate in moderate or strenuous exercise 4 hours per week, did not smoke cigarettes 
or drink alcohol. She did not report general stress prior to her stroke. I.C.’s BMI was 18.5 
at the time of her stroke. She was taking blood pressure and high cholesterol medication 
as well as aspirin prior to her stroke. She has 2 children.  
T.C. is the identical twin of I.C. She is 48 years old with a history of hypertension 
but not high cholesterol or diabetes mellitus. She reported that she participates in 
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moderate or strenuous exercise 4 hours or more per week and does not smoke cigarettes, 
drink alcohol or have general stress.  Her BMI is 23.6. She has 2 children. 
Biological and Environmental Risk Factors—by Family 
 Table 2 shows the biological and environmental risk factors for all participants. 
Hypertension was more prevalent than diabetes mellitus or cholesterol with 78.6% 
(11/14) of participants reporting a history of hypertension. The youngest participant with 
a diagnosis of hypertension was 35 years of age and the oldest participant was 84 years of 
age. Of the 3 remaining participants, 1 participant with a hemorrhagic stroke was 
unaware of his history. The other 2 remaining were non-hemorrhagic stroke participants 
who reported no history of hypertension. Family 4 had the highest percentage with 100% 
(4/4). Family 3 also had 100% (2/2) with episodic hypertension; however, neither 
participants was taking medication to regulate blood pressure at the time of their 
hemorrhagic stroke. In Family 1, 75% (3/4) reported hypertension. Family 2 had 50% 
(2/4) that reported hypertension; however, one participant with hemorrhagic stroke 
reported no knowledge of hypertension prior to the hemorrhagic stroke as he did not go 
to the doctor regularly.   
 High cholesterol was present in 42.9% (6/14) participants. Of those, Family 4 had 
the highest percentage with 75% (3/4). Family 2 had 50% (2/4) reporting high cholesterol 
although one family with a hemorrhagic stroke did not go to the doctor on a regular basis 
prior to his stroke so information was not available on him. Family 1 reported 25% (1/4) 
with high cholesterol and Family 3 had no participants with high cholesterol.  
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 Diabetes mellitus was present in 14.3% (2/14) participants. Family 1 accounted 
for both incidences of diabetes mellitus.  
 General stress, as measure by the self-identification on the questionnaire was 
present in 41.7% (6/14) of participants. No information was available on 2/14 (1 from 
Family 1 and 1 from Family 4) as these were deceased. Family 1 had 75% (3/4) reported 
general stress. The remaining person in Family 1 was deceased so no information was 
obtained about stress. Family 2 had 50% (2/4) participants who reported general stress 
and Family 3 had 50% (1/2) who reported general stress. No participants from Family 4 
reported general stress.  
 Alcohol use was reported in 57.1% (8/14) participants. Alcohol consumption was 
reported as 1-30 drinks per month by all but one participant. He reported >30 drinks per 
month. There were only 2/14 (14.3%) who reported smoking. Both of these were in 
Family 2 and also reported alcohol use.   
 Only 28.6% (4/14) reported that they participated in moderate or strenuous 
exercise 4 hours or more per week. Two were in Family 4 and 1 was in Family 3 and 1 
was in Family 2.  
Biological and Environmental Risk Factors—with Hemorrhagic Stroke 
 All participants 87.5% (7/8) with a hemorrhagic stroke reported hypertension 
prior to their stroke with the exception of one participant who did not go to the doctor 
regularly. Five of the eight (62.5%) participants were taking medication to regulate blood 
pressure. Two participants reported episodic hypertension and were not taking 
medication to regulate blood pressure at the time of their stroke.  
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 High cholesterol was reported by 50% (4/8) of the participants with hemorrhagic 
stroke. Again, one participant did not go to the doctor regularly so did not have any 
knowledge of his cholesterol levels; however, he does not currently have high 
cholesterol.  
Two participants (2/8, 25%) with hemorrhagic stroke reported taking an aspirin 
daily. Interestingly, these two participants, one from Family 1 and one from Family 4, 
both also had high cholesterol. 
 Diabetes mellitus was reported in 25% (2/8) participants with hemorrhagic stroke. 
Both of these were in Family 1.  
 Exercise was reported in 37.5% (3/8) participants with hemorrhagic stroke. Only 
1 participant (1/8, 12.5%) smoked cigarettes and he smoked >1 pack/day. He is also the 
only participant who reported consumption of   >30 alcoholic beverages a month.  
 General stress was reported in 37.5% (3/8) participants; however, information was 
not available regarding general stress on 2 participants who were deceased.  
Biological and Environmental Risk Factors—without Hemorrhagic Stroke 
 Hypertension was the most prevalent biological risk factor among participants 
without hemorrhagic stroke with 83.3% (5/6). Only 2/6 (12%) participants reported high 
cholesterol and no participants reported a history of diabetes mellitus.  
 Only 16.7% (1/6) reported strenuous exercise 4 or more hours per week.  
Cigarette smoking was reported in 33.3% (2/6) participants. Both smokers were from 
Family 2. Alcohol use was reported in 66.7% (4/6) participants. General stress was 
reported in 50% (3/6) participants.  
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Location of Hemorrhagic Stroke 
 Of the 8 participants with hemorrhagic stroke, 2 were deceased, and 1 did not 
know the location of her hemorrhagic stroke. Interestingly, 4/5 of the remaining 
participants with a hemorrhagic stroke reported that their hemorrhagic stroke occurred in 
the right hemisphere of the brain. Of the remaining 4 participants with hemorrhagic 
stroke, 3 reported a frontal lobe lesion and 1did not report a lobe location. One participant 
with hemorrhagic stroke reported that his hemorrhagic stroke was a SAH. None of the 
remaining participants reported type of hemorrhagic stroke.  
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Figure 1. Family 1 Pedigree 
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Figure 2. Family 2 Pedigree  
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Figure 3.  Family 3 Pedigree 
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Figure 4.  Family 4 Pedigree 
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Table 2. Biological and Environmental Risk Factors 
 
Family Participant HS HTN HC DM Exercise Smoke Alcohol GS  BMI 
Family 
1 
P.M. (II 3) + + - + - - + + 45.2 
 G.M. (I 2)  + + + + - - - un 26.5 
 W.M. (III 
2)  
- - - - - - + + 21.8 
 S.M. (III 
3)  
- + - - - - - + 21.8 
Family 
2 
A.D. (II 
1) 
+ + + - + - - + 33.3 
 B.D. (III 
1) 
+ un un un - ++ ++ - 26.2 
 G.D. (III 
2) 
- - - - - + + - 33.3 
 S.D. (III 
3) 
- + + - - + + + 36.0 
Family 
3 
H.N. (III 
1) 
+ +* - - + - + + 25.8 
 B.H. (II 
4) 
+ +* - - - - + - 20.6 
Family 
4 
M.C (II 1) + + + - - - - un 22.7 
 S.C. (III 
2) 
- + + - - - + - 26.6 
 I.C. (III 
3) 
+ + + - + - - - 18.5 
 T.C. (III 
4) 
- + - - + - - - 23.6 
HS = hemorrhagic stroke, HTN = hypertension, HC = high cholesterol, DM = diabetes 
mellitus, GS = general stress, BMI = body mass index, *= episodic hypertension, 
medication was not taken at time of stroke, un=unknown, ++= smoked >1 pack 
cigarettes/day and >30 alcoholic beverages/month 
 
 
HPLPII  
 Table 3 and Table 4 shows scores on the HPLPII by participant and HPLPII 
means scores and standard deviation by family.  Fisher’s exact test indicated no 
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significant difference between participant’s HPLPII score or between families’ HPLPII 
scores.  
Mann Whitney U Test was performed to compare biological and environmental 
risk factors with HPLPII scores among all participants. There was a significant difference 
in HPLPII—physical activity score and presence of high cholesterol (p=.048), HPLPII—
nutrition score and presence of high cholesterol (p=.048), and HPLPII—nutrition scores 
and reported general stress (p=.04). No other significance in distribution of HPLPII 
scores were observed among all participants.  
HPLPII scores for participants without hemorrhagic stroke were compared. 
Kolmogorov-Smirnov goodness-of-fit test showed a significant difference between 
individual participants without hemorrhagic stroke on the HPLPII—nutrition score 
( =2.74, SD=.381, p=.021).  
No significant difference was found when HPLPII scores for participants with 
hemorrhagic stroke were calculated. However, there was a significant difference in BMI 
between participants with hemorrhagic stroke and those without hemorrhagic stroke ( 
=27.35, SD=8.485, p=.046). 
Spearman rho correlation was computed to access the relationship between 
HPLPII scores and the biological and environmental risk factors associated with 
hemorrhagic stroke. There was a positive correlation between HPLPII—Physical Activity 
score and high cholesterol (rs=.648, n=12, p=.031); HPLPII—Physical Activity score and 
HDL (rs=.965, n=7, p=.000) and HPLPII—Health Responsibility score and Diabetes 
(rs=.583, n=12, p=.047).  
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PSS 
Table 5 shows PSS means and standard deviation by family. Fisher’s exact test 
revealed a significant difference between individual with hemorrhagic stroke when 
compared to those without hemorrhagic stroke (p=.026).  
Figure 5 shows PSS total scores by individual and family. A Mann-Whitney U 
Test indicated that PSS scores were significantly higher for participants with hemorrhagic 
stroke ( =24.33) than for participants without hemorrhagic stroke ( =15.67), U=4.0, 
p=.028). PSS scores were examined for association with environmental and biological 
risk factors and no significant association was found. However, there was a significant 
association between participants with hemorrhagic stroke PSS scores and HPLPII—
Nutrition scores (p=.174, Fisher’s exact test) compared to participants without 
hemorrhagic stroke. Spearman rho correlation was computed to assess the relationship 
between PSS scores and the biological and environmental risk factors of hemorrhagic 
stroke. There was a positive correlation between PSS score and age at time of stroke 
(rs=.928, n=6, p=.008). No other significant correlations were identified related to PSS. 
A spearman rho correlation was computed to assess the relationships between the 
biological risk factors for hemorrhagic stroke and the environmental risk factors for 
hemorrhagic stroke. There was a negative correlation between systolic blood pressure and 
alcohol use (rs= -.753. N=10, p=.012), and diastolic blood pressure and alcohol use (rs= -
.753. N=10, p=.012). There was a positive correlation between glucose levels and 
strenuous exercise 4 or more time a week (rs=.760, n=8, p=.028). No other significant 
correlations were indicated.
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Table 3. HPLPII Scores by Participant 
 
 HS TS HS PA Nu SG IR SM 
Family 1         
P.M. (II 3) + 2.75 3.56 1.38 2.89 3.00 3.00 2.75 
G.M. (I 2) + X X X X X X X 
W.M. (III 2) - 2.25 1.44 1.75 2.56 2.67 2.89 2.13 
S.M. (III 3) - 2.25 1.78 2.13 2.33 2.67 2.78 1.78 
Family 2         
A.D. (II 1) + 2.56 2.67 2.25 3.56 2.44 2.78 1.88 
B.D. (III 1) + 1.87 1.11 1.50 1.78 2.67 2.67 1.63 
G.D. (III 2) - 2.65 2.56 2.25 3.22 2.22 2.67 3.00 
S.D. (III 3) - 2.19 1.67 1.13 2.56 3.22 2.67 1.75 
Family 3         
H.N. (III 1) + 3.08 2.22 3.38 2.67 3.89 3.22 3.13 
B.H. (II 4) + 1.60 1.00 1.13 1.78 1.89 2.22 1.25 
Family 4         
M.C. (II 2) + X X X X X X X 
S.C. (III 2) - 2.57 2.00 1.25 3.22 3.33 3.44 2.00 
I.C. (III 3) + 3.54 3.33 3.63 2.89 3.78 3.22 4.00 
T.C. (III 4) - 2.69 1.77 2.00 2.56 3.67 3.67 2.25 
HPLPII = Health Promoting Lifestyles II;TS=HPLPII Total Score; HR= HPLPII Health 
Responsibility; PA= HPLPII Physical Activity; Nu = HPLPII Nutrition; SG = HPLPII 
Spiritual Growth; IR = HPLPII Interpersonal Relation; SM = Stress Management; X=no 
information—deceased; HS = hemorrhagic stroke 
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Table 4. Descriptive Statistics of HPLPII Scores by Family 
 
  Family 1 
n=3 
Family 2 
n=4 
Family 3 
n=2 
Family 4 
n=3 
 n Mean SD Mean SD Mean SD Mean SD 
TS 12 2.42 .289 2.32 .359 2.34 1.047 2.93 .520 
HR 12 2.26 1.139 2.00 .745 1.61 .863 2.37 .842 
PA 12 1.75 .375 1.78 .561 2.26 1.591 2.29 1.217 
Nu 12 2.59 .281 2.78 .785 2.23 .629 2.89 .330 
SG 12 2.78 .191 2.67 .430 2.89 1.414 3.59 .235 
IR 12 2.89 .110 2.70 .055 2.72 .707 3.44 .225 
SM 12 2.21 .504 2.07 .632 2.19 1.329 2.75 1.089 
HPLPII = Health Promoting Lifestyles II; TS=HPLPII Total Score; HR= HPLPII Health 
Responsibility; PA= HPLPII Physical Activity; Nu = HPLPII Nutrition; SG = HPLPII 
Spiritual Growth; IR = HPLPII Interpersonal Relation; SM = Stress Management  
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Figure 5. PSS Scores  
 
PSS = Perceived Stress Scale; low perceived stress = 0-13, moderate perceived stress = 
14-26, high perceived stress = 27-40 
 
 
Table 5. PSS Descriptive Statistics  
 
 
 Family 1 
n=3 
Family 2 
n=4 
Family 3 
n=2 
Family 4 
n=3 
 n Mean SD Mean SD Mean SD Mean SD 
PSS 
Score 
12 18.67 4.16 19.25 10.05 27.5 3.54 17.33 3.79 
PSS = Perceived Stress Scale; low perceived stress = 0-13, moderate perceived stress = 
14-26, high perceived stress = 27-40 
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CHAPTER V 
DISCUSSION 
 
 
 The aim of this research study was to identify biological and environmental risk 
factor associated with hemorrhagic stroke by examining the similarities and differences 
between and within families with a history of hemorrhagic stroke.  The resulting 
biological risk factors associated with hemorrhagic stroke in this study were somewhat 
similar to expectations based on current literature. Hypertension was the biological risk 
factor most associated with hemorrhagic stroke followed by high cholesterol and then 
diabetes mellitus. The environmental factors considered for this study, exercise, smoking, 
alcohol consumption, and general stress, were more ambiguous.  
Hypertension was prevalent in all four families and was the most salient 
biological risk factor among all study participants (87.7%, 12/14). The penetrance of 
hypertension in the general population is approximately 32% for ages 40-59 and 65% for 
ages 60 and older (Yoon, Fryar & Carroll, 2015). The youngest participant in this study 
was 37 and the oldest, at time of stroke, was 65. Interestingly, 5/8 participants with 
hemorrhagic stroke had a diagnosis of hypertension prior to their stroke and were taking 
medication for blood pressure management. Two participants with hemorrhagic stroke 
had episodic hypertension prior to their stroke, but were not on medication for blood 
pressure management, and one participant with hemorrhagic stroke did not go to the 
doctor regularly and had no medical records identifying him with hypertension. All non-
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hemorrhagic stroke participants who had a diagnosis of hypertension were taking 
medication for blood pressure management. These results support previous literature that 
hypertension is a major risk factor for hemorrhagic stroke. It is compelling that a large 
portion of the non-hemorrhagic stroke family members also has hypertension in a greater 
percentage than what would be expected in the general population. Hypertension, like 
hemorrhagic stroke, aggregates within families. It is unclear if hypertension is the 
precipitance in this study or if there is an underlying, unknown variable. Unfortunately, 
no information was available regarding age of diagnosis of high blood pressure. Also, it 
is unclear if any of the participants taking medication for blood pressure control were 
actually managing their blood pressure.  
 High cholesterol was reported in 42.9% (6/14) participants, which is much higher 
than the general population at 12.1% (National Center for Health Statistics, 2016). All 
participants with high cholesterol reported taking medication for lowering cholesterol 
levels. Family 2 and Family 4 reported higher incidences of high cholesterol (2/4 and 3/4 
respectively), whereas Family 3 (0/2) reported no history of high cholesterol, and Family 
1 had only 1/4 participant with high cholesterol. Of the 8 participants with hemorrhagic 
stroke, 4 reported high cholesterol prior to their stroke. Cholesterol levels were obtained 
by 2/4 participants. Of these, both reported LDLs within the normal range, 96 mg/dL and 
121 mg/dL. Although Sturgeon and colleagues (2007) found that low LDL was 
significantly associated with ICH, participants with hemorrhagic stroke in this study did 
not. Only one participant with hemorrhagic stroke reported his type of hemorrhagic 
stroke as SAH. No other study participants reported the type of hemorrhagic stroke. 
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There is no evidence to support that high cholesterol is unequivocally association with 
hemorrhagic stroke type; however, the high proportion of participants with high 
cholesterol in this study is indicative of high cholesterol clustering within families, which 
may be a risk factor for hemorrhagic stroke among those families.  
 As in previous studies (Howard et al. 2013; Kissela et al., 2002; Matsukawa et al., 
2012), diabetes mellitus was not associated with hemorrhagic stroke in this study. It was 
reported in only 2/14 (14.3%) participants, and both of these cases were in participants 
with hemorrhagic stroke within the same family (Family 1).  
Moderate or strenuous exercise 4 hours or more per week was reported in 4/14 
(28.6%) participants. Of these, 3 (one each from Family 2, Family 3, Family 4) had a 
hemorrhagic stroke and 1(from Family 4) did not.  It is interesting that 3/8 (37.5%) of 
participants with hemorrhagic stroke reported moderate or strenuous exercise 4 hours or 
more per week. However, the amount of time that passed between participants’ last 
exercise session and the event of their hemorrhagic stroke was unknown. Exercise 
increases blood pressure. In mouse models, mutations of the COL4A1/COL4A2 gene 
significantly increased the risk of hemorrhagic stroke. In addition to this, the test subjects 
that were exposed to more strenuous exercise exhibited an increased risks of hemorrhagic 
stroke. Lee and colleagues (1999) found that the relative risk of hemorrhagic stroke was 
borderline significant with increased frequency of vigorous exercise (p for trend=0.07 
and 0.68). Results here suggests that there could possibly be a stronger link between 
exercise and hemorrhagic stroke for those individuals with a strong family history of 
hemorrhagic stroke.  
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Alcohol consumption was reported in all families (8/14, 57.1%) and cigarette 
smoking in Family 2 (3/4) only.  
Stress is a difficult concept to define as each individual perceives stress 
differently. What one person may consider a very stressful situation, another may not 
consider stressful at all. On the health history questionnaire, general stress was reported 
in all families (6/12, 50%). PSS scores were significantly higher for participants with 
hemorrhagic stroke (all reported moderate to high perceived stress) than those without 
hemorrhagic stroke (all reported low to moderate perceived stress). This strongly 
suggests that perceived stress may be related to hemorrhagic stroke. As stress is known to 
increase blood pressure, it may be an important consideration for future research.  
The greatest variability in HPLPII scores occurred on the HPLPII—Nutrition 
score and HPLPII—Physical Activity score. Since nutrition and physical activity habits 
are closely related, it is not surprising that these two areas would have the greatest 
variability.  
Limitations and Future Research 
 There are several limitations that should be considered in this study. First, the 
sample size was quite small with only 4 families participating. Results may not be 
generalized beyond the specific population from which the sample was drawn, however, 
it is a starting point and has demonstrated that is feasible to complete a multigenerational, 
multi-family study on hemorrhagic stroke.    
All information provided for this study was self-reported from participants. 
Participants filled out questionnaires and were requested to obtain their medical records 
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and share those with researchers. Unfortunately, many participants had difficulty 
obtaining copies of their medical records from their physician’s office. Some information 
was not reported in the medical records and therefore some information was not 
completed on the questionnaires. In one instance, the participant requested their medical 
records, but their medical records were not received. In another instance, the participant 
reported that it had been 20 years since her hemorrhagic stroke and her medical records 
were not available. In all other missing cases, participants either did not request their 
medical records or refused to share their medical records with researchers. Researchers 
did not have access to the medical records so information obtained on the medical history 
questionnaire could not be verified.  
For those participants with hemorrhagic stroke, it had been at least 3 to as long as 
20 years since their stroke. Participants may have forgotten specific information related 
to their hemorrhagic stroke or their personal habits or their perceived stress prior to their 
stroke. Even though they were requested to fill out the HPLPII and PSS to the best of 
their knowledge with information prior to their stroke, they could have failed to 
remember information.  
Another limitation to this study was that the pedigrees discussed were incomplete. 
All first and second-degree relatives were not listed, as their information was not 
available. Again, participants obtained information about family member’s medical 
history. The information given may have been incorrect, inaccurate and/or incomplete. 
The one disease that all participants knew and discussed was hypertension. This could be 
because a majority of participants had a diagnosis of hypertension, which could make 
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them hyperaware of others with the same disease or they could have over projected the 
diagnosis of hypertension while under projecting other medical diagnosis, such as high 
cholesterol and diabetes mellitus.  
Age of onset of disease is as important as the disease itself. This information was 
not asked by researchers and thus not given. The age at which a disease is first diagnosed 
is important especially as it pertains to hypertension which can often be controlled with 
medication. As hypertension was the biological risk factor most closely associated with 
hemorrhagic stroke in this study, understanding when someone was diagnosed and what 
regiment the individual is doing to regulate blood pressure would add a lot to the 
knowledge.  
Future studies could focus on how communication between family physicians and 
patients occur. Precision medicine requires that correct and thorough information be 
provided by patients and interpreted by the physician. Clearly, based on the incomplete 
information provided by participants, there is a gap in information and/or understanding 
of medical and family history. It is unclear if participants in this study did not truly 
understand the risk factors of hemorrhagic stroke or if they were never informed of the 
risks. It could be that physicians do not understand that patients with a strong family 
history of hemorrhagic stroke have an increased risk of hemorrhagic stroke, because they 
are not given complete information from patients. This could create a failure to identify 
high risk populations.  
There does not seem to be one clear biological or environmental factor that can be 
identified as the “cause” of hemorrhagic stroke. Instead, there appear to be different 
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influences that differ by family.  High blood pressure seems to be the most common 
element. BP can change throughout the day due to stress, posture changes, exercise or 
sleep. Because a large portion of participants had a diagnosis of hypertension, it would be 
fortuitous to consider elements associated with hypertension for those with a family 
history of hemorrhagic stroke more closely, especially perceived stress. In addition, more 
multi-family, multi-generational pedigrees need to be completed for comparison.  
This study identified 4 families with a strong history of hemorrhagic stroke. In the 
future, these families could be utilized for genetic testing. Genetic testing can reveal 
variations in genes, chromosomes or proteins that may have an effect on a person’s 
health.  Completing genetic testing on family members with hemorrhagic stroke and 
comparing the results with non-effected members may show variations of a gene, protein 
or chromosome between the groups that may lead researchers to a better understanding of 
the cause(s) of hemorrhagic stroke within families.  
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APPENDIX A 
PARTICIPANT QUESTIONNAIRE FOR HEMORRHAGIC STROKE 
PARTICIPANTS  
 
1. Please complete the following chart by circling your response. 
Ethnicity Do you have 
hypertension? 
Do you have 
high 
cholesterol? 
Do you have 
Diabetes 
Mellitus? 
Do you take 
high-risk 
medications? 
American 
Indian or 
Alaska Native 
 
Asian 
 
Black/African 
American 
 
Hispanic/Latino 
 
Native 
Hawaiian or 
Other Pacific 
Islander 
 
White 
 
Other  
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
 
2. Sex:   Male  Female 
3. Prior to your stroke did you do moderate or strenuous exercise 4 hours or more 
per week? For example, did you do an activity such as fast walking or aerobics 
where your heart beats faster than normal, where you can talk but not sing? 
 YES NO 
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4. Prior to your stroke, did you drink alcohol? YES NO 
If yes, how much/often: 
_____1-30 drinks per month  _____More than 30 drinks per month 
_____More than 5 drinks per day at least 1 time a month 
5. Prior to your stroke, did you smoke cigarettes?  YES NO 
If yes, how much: _____More than 1 pack/day _____Less than 1 pack/day 
6. Prior to your stroke, did you experience unexpected general stress at home and/or 
in the workplace?   YES NO 
7. How many children do you have?  ______ 
8. How many siblings do you have? ______ 
9. How many aunts/uncles do you have?  _____ 
10. Do you have a first-degree blood relative (mother, father, brother, sister) or 
second-degree blood relative (aunt, uncle, grandparent, grandchildren) who has 
had a stroke before the age of 65? YES NO 
11. If you answered yes to number 9, please complete the chart.  
Relationship Age at stroke High blood 
pressure 
Diabetes 
Mellitus 
High 
cholesterol  
Mother     
Father     
Child 1     
Child 2     
Child 3     
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Child 4     
Sibling 1     
Sibling 2     
Sibling 3     
Sibling 4     
Mother’s 
mother 
    
Mother’s father     
Father’s mother     
Father’s father     
Aunt 1     
Aunt 2     
Aunt 3     
Aunt 4     
Uncle 1     
Uncle 2     
Uncle 3     
Uncle 4     
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APPENDIX B 
QUESTIONNAIRE FOR NON-HEMORRHAGIC PARTICIPANTS 
 
1. Please complete the following chart by circling your response. 
Ethnicity Do you have 
hypertension 
Do you have 
high 
cholesterol 
Do you 
have 
Diabetes 
Mellitus 
Do you take 
high risk 
medications 
American 
Indian or 
Alaska Native 
 
Asian 
 
Black/African 
American 
 
Hispanic/Latino 
 
Native 
Hawaiian or 
Other Pacific 
Islander 
 
White 
 
Other  
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
 
2. Sex:  Male  Female 
3. Do you do moderate or strenuous exercise 4 hours or more per week? For 
example, did you do an activity such as fast walking or aerobics where your heart 
beats faster than normal; where you can talk but not sing?  YES NO 
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4. Do you drink alcohol? YES NO 
If yes, how much/often: 
_____1-30 drinks per month  _____More than 30 drinks per month 
_____More than 5 drinks per day at least 1 time a month 
5. Do you smoke cigarettes?  YES NO 
If yes, how much: _____More than 1 pack/day _____Less than 1 pack/day 
If no, have you ever smoked?  YES NO 
6. Do you experience unexpected general stress at home and/or in the workplace?  
 YES NO 
7. How many children do you have?  ______ 
8. How many siblings do you have? ______ 
9. How many aunts/uncles do you have?  _____ 
10. Do you have a first-degree blood relative (mother, father, brother, sister) or 
second-degree blood relative (aunt, uncle, grandparent, grandchildren) who has 
had a stroke before the age of 65? YES NO 
11. If you answered yes to number 9, please complete the chart.  
Relationship Age at 
stroke 
High blood 
pressure 
Diabetes 
Mellitus 
High 
cholesterol  
Mother     
Father     
Child 1     
Child 2     
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Child 3     
Child 4     
Sibling 1     
Sibling 2     
Sibling 3     
Sibling 4     
Mother’s mother     
Mother’s father     
Father’s mother     
Father’s father     
Aunt 1     
Aunt 2     
Aunt 3     
Aunt 4     
Uncle 1     
Uncle 2     
Uncle 3     
Uncle 4     
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APPENDIX C 
MEDICAL CHART REVIEW FOR PARTICIPANTS WITH HEMORRHAGIC 
STROKE 
 
ID Number At time of admittance History prior to stroke  
Age at time of 
hemorrhagic stroke 
 
 
 
Location of 
hemorrhagic stroke 
 
 
 
Blood pressure   
 
 
Cholesterol level  
 
 
Blood glucose levels   
 
 
High risk 
medications  
 
 
 
BMI  
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APPENDIX D 
MEDICAL CHART REVIEW FOR NON-HEMORRHAGIC PARTICIPANTS  
 
ID Number  
Age at time of hemorrhagic stroke  
 
Blood pressure   
 
Cholesterol   
 
Blood glucose levels   
 
High risk medications   
 
BMI  
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APPENDIX E 
 
PRECEIVED STRESS SCORE (PSS) 
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APPENDIX F 
 
HEALTH PROMOTING LIFESTYLE PROFILE II (HPLPII) 
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